Skip to main content
Log in

Double-lung versus heart–lung transplantation for end-stage cardiopulmonary disease: a systematic review and meta-analysis

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

We compared posttransplant outcomes following double-lung transplantation (DLTx) and heart–lung transplantation (HLTx), based on a search of PubMed, Cochrane Library, and Embase, from inception to March 8, 2022, for studies that report outcomes of these procedures. We then performed a meta-analysis of baseline characteristics and posttransplant outcomes. Subgroup analyses were implemented according to indication, publication year, and center. This study was registered on PROSPERO (number CRD42020223493). Ten studies were included in this meta-analysis, involving 1230 DLTx patients and 1022 HLTx patients. The DLTx group was characterized by older donors (P = 0.04) and a longer allograft ischemia time (P < 0.001) than the HLTx group. The two groups had comparable 1-year, 3-year, 5-year, 10-year survival rates (all P > 0.05), with similar results identified in subgroup analyses. We found no significant differences in 1-year, 5-year, and 10-year chronic lung allograft dysfunction (CLAD)-free survival, length of intensive care unit stay and hospital stay, length of postoperative ventilation, in-hospital mortality, or surgical complications between the groups (all P > 0.05). Thus, DLTx provides similar posttransplant survival to HLTx for end-stage cardiopulmonary disease. These two procedures have a comparable risk of CLAD and other posttransplant outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306(10):557–64.

    Article  CAS  PubMed  Google Scholar 

  2. Kramer MR, Valantine HA, Marshall SE, Starnes VA, Theodore J. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol. 1994;73(7):494–500.

    Article  CAS  PubMed  Google Scholar 

  3. Moulton MJ, Creswell LL, Ungacta FF, Downing SW, Szabó BA, Pasque MK. Magnetic resonance imaging provides evidence for remodeling of the right ventricle after single-lung transplantation for pulmonary hypertension. Circulation. 1996;94(9 Suppl): Ii312–9.

  4. Chambers DC, Cherikh WS, Harhay MO, Hayes D Jr, Hsich E, Khush KK, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transp. 2019;38(10):1042–55.

    Article  Google Scholar 

  5. López-Meseguer M, Quezada CA, Ramon MA, Lázaro M, Dos L, Lara A, et al. Lung and heart-lung transplantation in pulmonary arterial hypertension. PLoS One. 2017;12(11): e0187811.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yusen RD, Edwards LB, Dipchand AI, Goldfarb SB, Kucheryavaya AY, Levvey BJ, et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transp. 2016;35(10):1170–84.

    Article  Google Scholar 

  7. Chambers DC, Cherikh WS, Goldfarb SB, Hayes D Jr, Kucheryavaya AY, Toll AE, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation. J Heart Lung Transp. 2018;37(10):1169–83.

    Article  Google Scholar 

  8. Brouckaert J, Verleden SE, Verbelen T, Coosemans W, Decaluwé H, De Leyn P, et al. Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study. Transpl Int. 2019;32(7):717–29.

    Article  CAS  PubMed  Google Scholar 

  9. Hill C, Maxwell B, Boulate D, Haddad F, Ha R, Afshar K, et al. Heart–lung vs. double-lung transplantation for idiopathic pulmonary arterial hypertension. Clin Transp. 2015;29(12): 1067–75.

  10. Sertic F, Han J, Diagne D, Richards T, Chavez L, Berg A, et al. Not all septal defects are equal: outcomes of bilateral lung transplant with cardiac defect repair vs combined heart–lung transplant in patients with eisenmenger syndrome in the United States. Chest. 2020;158(5):2097–106.

    Article  PubMed  Google Scholar 

  11. Vricella LA, Karamichalis JM, Ahmad S, Robbins RC, Whyte RI, et al. Reitz, lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the stanford experience. Ann Thorac Surg. 2002;74(1): 13–7 (discussion 17–8)

  12. Swaminathan AC, Todd JL, Palmer SM. Advances in human lung transplantation. Annu Rev Med. 2021;27(72):135–49.

    Article  Google Scholar 

  13. Narula J, Bennett LE, DiSalvo T, Hosenpud JD, Semigran MJ, Dec GW. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation. 1997;63(6):861–7.

    Article  CAS  PubMed  Google Scholar 

  14. Ganesh JS, Rogers CA, Bonser RS, Banner NR. Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study. Eur Respir J. 2005;25(6):964–9.

    Article  CAS  PubMed  Google Scholar 

  15. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350: g7647.

    Article  PubMed  Google Scholar 

  17. Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.

    Article  PubMed  Google Scholar 

  18. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tian D, Wang Y, Shiiya H, Sun CB, Uemura Y, Sato M, et al. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2020;159(2):720-730.e6.

    Article  PubMed  Google Scholar 

  21. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

    Article  PubMed  Google Scholar 

  22. Egger M, Davey Smith G, Schneider M, Minder C, Schneider, C. Minder. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109): 629–34

  23. de Perrot M, Granton JT, McRae K, Pierre AF, Singer LG, Waddell TK, et al. Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience. J Thorac Cardiovasc Surg. 2012;143(4):910–8.

    Article  PubMed  Google Scholar 

  24. Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Ann Thorac Surg, 2006;81(1): 286–91 (discussion 291)

  25. Burton CM, Milman N, Carlsen J, Arendrup H, Eliasen K, Andersen CB, et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Trans. 2005;24(11):1834–43.

    Article  Google Scholar 

  26. Fadel E, Mercier O, Mussot S, Leroy-Ladurie F, Cerrina J, Chapelier A, et al. Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients. Eur J Cardiothorac Surg. 2010;38(3):277–84.

    Article  PubMed  Google Scholar 

  27. Wahlers T, Haverich A, Schäfers HJ, Hirt SW, Fieguth HG, Jurmann M, et al. Chronic rejection following lung transplantation. Incidence, time pattern and consequences. Eur J Cardiothorac Surg. 1993;7(6): 319–23 (discussion 324)

  28. Ueno T, Smith JA, Snell GI, Williams TJ, Kotsimbos TC, Rabinov M, et al. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger’s syndrome. Ann Thorac Surg. 2000;69(2):381–7.

    Article  CAS  PubMed  Google Scholar 

  29. Lordan JL, Corris PA. Pulmonary arterial hypertension and lung transplantation. Expert Rev Respir Med. 2011;5(3):441–54.

    Article  PubMed  Google Scholar 

  30. Habedank D, Ewert R, Hummel M, Dandel M, Habedank F, Knosalla C, et al. The effects of bilateral lung transplantation on ventilatory efficiency, oxygen uptake and the right heart: a 2-year follow-up. Clin Transpl. 2011;25(1):E38-45.

    Article  Google Scholar 

  31. Franke U, Wiebe K, Harringer W, Franke T, Wittwer T, Wahlers T, et al. Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension. Eur J Cardiothorac Surg. 2000;18(4):447–52.

    Article  CAS  PubMed  Google Scholar 

  32. Shigemura N, Sareyyupoglu B, Bhama J, Bonde P, Thacker J, Bermudez C, et al. Combining tricuspid valve repair with double lung transplantation in patients with severe pulmonary hypertension, tricuspid regurgitation, and right ventricular dysfunction. Chest. 2011;140(4):1033–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. McCurry KR. Brief overview of lung, heart, and heart-lung transplantation. Crit Care Clin. 2019;35(1):1–9.

    Article  PubMed  Google Scholar 

  34. Bando K, Armitage JM, Paradis IL, Keenan RJ, Hardesty RL, Konishi H, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1994;108(6):1056–65.

    Article  CAS  PubMed  Google Scholar 

  35. Olland A, Falcoz PE, Canuet M, Massard G. Should we perform bilateral-lung or heart–lung transplantation for patients with pulmonary hypertension? Interact Cardiovasc Thorac Surg. 2013;17(1):166–70.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Pielsticker EJ, Martinez FJ, Rubenfire M. Lung and heart-lung transplant practice patterns in pulmonary hypertension centers. J Heart Lung Transp. 2001;20(12):1297–304.

    Article  CAS  Google Scholar 

  37. Goerler H, Simon A, Gohrbandt B, Hagl C, Oppelt P, Weidemann J, et al. Heart-lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience. Eur J Cardiothorac Surg. 2007;32(6):926–31.

    Article  PubMed  Google Scholar 

  38. Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transp. 2002;21(7):731–7.

    Article  Google Scholar 

  39. Kearney K, Lau EM, Darley D, Romfh A, Bart N, Kotlyar E, et al. Waitlist and post-transplant outcomes for eisenmenger syndrome: a comparison of transplant strategies. J Heart Lung Transp. 2021;40(8):841–9.

    Article  Google Scholar 

  40. Barlow CW, Robbins RC, Moon MR, Akindipe O, Theodore J, Reitz BA. Heart-lung versus double-lung transplantation for suppurative lung disease. J Thorac Cardiovasc Surg. 2000;119(3):466–76.

    Article  CAS  PubMed  Google Scholar 

  41. Toyoda Y, Thacker J, Santos R, Nguyen D, Bhama J, Bermudez C, et al. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg. 2008;86(4):1116–22.

    Article  PubMed  Google Scholar 

  42. Pinderski LJ, Kirklin JK, McGiffin D, Brown R, Naftel DC, Young KR Jr, et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transp. 2005;24(11):1828–33.

    Article  Google Scholar 

  43. Keenan RJ, Bruzzone P, Paradis IL, Yousem SA, Dauber JH, Stuart RS, et al. Similarity of pulmonary rejection patterns among heart-lung and double-lung transplant recipients. Transplantation. 1991;51(1):176–80.

    Article  CAS  PubMed  Google Scholar 

  44. Takahashi T, Terada Y, Pasque MK, Itoh A, Nava RG, Puri V, et al. Comparison of outcomes in lung and heart transplant recipients from the same multiorgan donor. Clin Transp. 2020;34(1): e13768.

    Article  Google Scholar 

  45. Yang YL, Xiang ZJ, Yang JH, Wang WJ, Xu ZC, Xiang RL. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J. 2020;41(46):4415–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all authors of the articles that were included in this systematic review and meta-analysis, especially Dr. Dirk Van Raemdonck and colleagues (Department of Thoracic Surgery, University Hospitals Leuven) who provided unpublished data for this study after we contacted them by email. We appreciate the American Journal Experts (https://secure.aje.com/cn/researcher/) for editing the English text of a draft of this manuscript.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hong-Ying Wen or Dong Tian.

Ethics declarations

Conflict of interest

We have no conflicts of interest to declare in relation to this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 791 kb)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yan, HJ., Zheng, XY., Huang, H. et al. Double-lung versus heart–lung transplantation for end-stage cardiopulmonary disease: a systematic review and meta-analysis. Surg Today 53, 1001–1012 (2023). https://doi.org/10.1007/s00595-022-02579-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-022-02579-4

Keywords

Navigation